News | February 02, 2012

Aria Health First on East Coast to Use Epoch System to Treat Arrhythmias

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D.,

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D., FACC Scott Spielman, M.D., FACC and Bradley Bacik, DO, FACC, are the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System, to perform robotic ablation of heart arrhythmias.


February 2, 2012 — Aria Health, the largest healthcare provider in Northeast Philadelphia and Bucks County, is the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System. This innovative technology allows electrophysiologists to treat many types of cardiac arrhythmias, or heart rhythm disorders, with robotic-driven catheter ablation procedures.

Housed in the heart center at Aria Health’s Torresdale Campus, Epoch offers many advantages over conventional treatment methods, according to Scott Spielman, M.D., FACC, director of Aria’s electrophysiology laboratory.

"Standard catheters used for ablation are fairly stiff, making them difficult to guide and raising the risk of perforating heart tissue,” said Spielman.  “The Epoch system employs a soft, floppy catheter which enables us to complete procedures in a shorter time period with greater safety.”

The new system reduces patient radiation exposure by two-thirds, and is effective for treating ventricular arrhythmias as well as other types of abnormal heart rhythms.

“This allows us to get a catheter tip to sites inside the complex internal anatomy with less force and more precision,” said Roger Marinchak, M.D., FACC, an electrophysiologist at Aria Health.  “This causes less risk of causing perforation injury to structures that one doesn’t want to ablate or hurt."

As the United States population ages, the number of people with atrial fibrillation (AF) - the most common type of serious arrhythmia - will grow, says Aria electrophysiologist Bradley Bacik, DO, FACC. While AF is a chronic condition that cannot be cured, he adds, ablation treatments available at Aria Health can substantially reduce symptoms.

For more information: www.ariahealth.org


Related Content

News

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
Home
News

Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...

Home September 05, 2025
Home
News

Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...

Home September 03, 2025
Home
News

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
Home
News

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

Home July 09, 2025
Home
News

June 4, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...

Home June 04, 2025
Home
News

April 24, 2025 – The Heart Rhythm Society (HRS) and the American College of Cardiology (ACC) have released a scientific ...

Home April 24, 2025
Home
News

April 9, 2025 — Merit Medical Systems has announced the U.S. commercial release of its Ventrax Delivery System. Ventrax ...

Home April 16, 2025
Home
News

March 27, 2025 — Abbott recently announced it has received CE Mark in Europe for the Volt PFA System to treat patients ...

Home March 27, 2025
Home
News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
Subscribe Now